[1]
Klotz, L., Breau, R.H., Collins, L.L., Gleave, M.E., Pickles, T., Pouliot, F. and Saad, F. 2017. Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer. Canadian Urological Association Journal. 11, 1-2 (Feb. 2017), 16–23. DOI:https://doi.org/10.5489/cuaj.4303.